Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

Abstract: The invention relates to aryl and heteroaryl substituted compounds of Formula (I), and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein G, R1, and Z1-Z5 are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. Compounds of the present invention are especially useful for treating pain.

Abstract: A modular, reusable temporary enclosure system is particularly suited for the renovation of buildings having stacked concrete floors supported by steel and/or concrete columns. The system consists of a set of track components, one fastened to the floor, and one fastened to the ceiling. Columns assembled from rigid panels are supported and aligned between these components. The panel edges are connected to one another by an interfacing spline assembly. To ensure that the components can be brought up to the construction site by elevator, individual panels are shorter than the full distance between the floors.

Abstract: A paper based cellulosic dunnage for use during transportation of goods. The dunnage may include an inner core, with a plurality of vertically aligned cellulosic cells that may be hexagonal in shape. The dunnage may include a top linerboard, attached to the top surface of the inner core, and corner boards, attached to the top and side surfaces of the inner core.

Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

Abstract: A paper based cellulosic dunnage for use during transportation of goods. The dunnage may include an inner core, with a plurality of vertically aligned cellulosic cells that may be hexagonal in shape. The dunnage may include a top linerboard, attached to the top surface of the inner core, and corner boards, attached to the top and side surfaces of the inner core.

Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

Abstract: The present invention relates to C-terminal modified Protoxin II peptides that selectively inhibit the Nav1.7 sodium channel; the present invention also relates to pharmaceutical compositions useful for prophylactic or therapeutic treatment of a disorder responsive to the blockade of sodium ion channels, especially Nav1.7 sodium ion channels; the present invention further provides methods of treating a disorder responsive to the blockade of sodium channels, and particularly Nav1.7 sodium channels, in a mammal sulfuring from excess activity of said channels.

Abstract: Embodiments disclosed herein are directed to integrated combustion assemblies including a perforated flame holder, combustion systems that include one or more integrated combustion assemblies, and related methods. For example, an integrated combustion assembly may be placed into service (e.g., integrated into a combustion system) as a complete and/or replaceable unit, such that elements and/or components of the combustion assembly are preassembled and no further assembly is required at the installation site.

Abstract: The present invention relates to C-terminal modified Protoxin II peptides that selectively inhibit the Nav1.7 sodium channel; the present invention also relates to pharmaceutical compositions useful for prophylactic or therapeutic treatment of a disorder responsive to the blockade of sodium ion channels, especially Nav1.7 sodium ion channels; the present invention further provides methods of treating a disorder responsive to the blockade of sodium channels, and particularly Nav1.7 sodium channels, in a mammal suffering from excess activity of said channels.

Abstract: The tablet computer handle includes a handle from which an expandable frame extends. The expandable frame is further defined with a left armature that telescopes with respect to a right armature. The left armature and the right armature are adapted to support a tablet computer therein. The handle is manually grasped in order to adaptively support the tablet computer. The handle includes at least one button that when depressed communicates a function with the tablet computer via a transmitter integrated in the handle.

Abstract: A power plant includes a boiler, a steam turbine, a generator driven by that steam turbine, a condenser, a post combustion processing system and an energy storage system including at least one electrochemical cell to store excess electrical energy generated by the generator during period valley demand and release thermal energy for power plant operations at other times.

Abstract: The present invention relates to C-terminal modified Protoxin II peptides that selectively inhibit the Nav1.7 sodium channel; the present invention also relates to pharmaceutical compositions useful for prophylactic or therapeutic treatment of a disorder responsive to the blockade of sodium ion channels, especially Nav1.7 sodium ion channels; the present invention further provides methods of treating a disorder responsive to the blockade of sodium channels, and particularly Nav1.7 sodium channels, in a mammal suffering from excess activity of said channels.

Abstract: A contaminant-tolerant hybrid scrubbing solvent is provided for post-combustion CO2 capture and removal, the scrubbing solvent including an amine and a low fraction of ammonia. A stripping carrier having a low latent energy is included for solvent regeneration. In one embodiment, the amine is MEA and the stripping chemical having low latent energy is pentane or an isomer thereof. Processes and apparatus for CO2 removal from post-combustion gases and for solvent regeneration are described.

Abstract: A power plant includes a boiler, a steam turbine, a generator driven by that steam turbine, a condenser, a post combustion processing system and an energy storage system including at least one electrochemical cell to store excess electrical energy generated by the generator during period valley demand and release thermal energy for power plant operations at other times.

Abstract: A contaminant-tolerant hybrid scrubbing solvent is provided for post-combustion CO2 capture and removal, the scrubbing solvent including an amine and a low fraction of ammonia. A stripping carrier having a low latent energy is included for solvent regeneration. In one embodiment, the amine is MEA and the stripping chemical having low latent energy is pentane or an isomer thereof. Processes and apparatus for CO2 removal from post-combustion gases and for solvent regeneration are described.